Your browser doesn't support javascript.
loading
Development and biological assessment of MMAE-trastuzumab antibody-drug conjugates (ADCs).
Yaghoubi, Sajad; Gharibi, Tohid; Karimi, Mohammad Hossein; Sadeqi Nezhad, Muhammad; Seifalian, Alexander; Tavakkol, Reza; Bagheri, Nader; Dezhkam, Asiyeh; Abdollahpour-Alitappeh, Meghdad.
Affiliation
  • Yaghoubi S; Department of Clinical Microbiology, Iranshahr University of Medical Sciences, Iranshahr, Iran.
  • Gharibi T; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Karimi MH; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Sadeqi Nezhad M; Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Seifalian A; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Gorgan, Iran.
  • Tavakkol R; Stem Cells and Regenerative Medicine Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
  • Bagheri N; Nanotechnology and Regenerative Medicine Commercialization Centre (Ltd), The London BioScience Innovation Centre, London, UK.
  • Dezhkam A; Department of Nursing, School of Nursing, Larestan University of Medical Sciences, Larestan, Iran.
  • Abdollahpour-Alitappeh M; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Breast Cancer ; 28(1): 216-225, 2021 Jan.
Article in En | MEDLINE | ID: mdl-32889587

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Breast Neoplasms / Receptor, ErbB-2 / Immunoconjugates / Trastuzumab Type of study: Prognostic_studies Limits: Humans Language: En Journal: Breast Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Breast Neoplasms / Receptor, ErbB-2 / Immunoconjugates / Trastuzumab Type of study: Prognostic_studies Limits: Humans Language: En Journal: Breast Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: